We’re excited to share some promising results from a recent clinical trial that holds great promise for treating Type 1 diabetes. This ground-breaking research was presented at the American Diabetes Association’s 83rd Scientific Sessions on June 23, 2023....
At Cells4Life, we are always keen to share encouraging developments in the field of regenerative medicine. Today, we bring you an exciting update from Bayer’s (OTC:BAYRY) subsidiary BlueRock, who have reported initial success in treating Parkinson’s...
In 2017, Eric Lyons, an American living in Cambodia, suffered a traumatic brain injury after hitting his head ‘very strongly’ on a door frame. According to Parents’ Guide to Cord Blood Banking: “His doctors explained to him that brain injury is...
HIV (human immunodeficiency virus) is a virus that many people may have heard of, frequently featuring in the news, where over time, the conversation has thankfully turned towards potential cures. It is a virus which attacks the body’s immune system, mainly...
Alzheimer, regrettably, is a well-known disease. Charities and organisations all over the world want to educate people on what it is, how to identify it and ways we can support both the individuals affected and their families. Enter World Alzheimer’s Day. Annually on...
A new Phase 1a open-label single-centre study is underway to assess the safety of administering DUOC-01 cells to adult patients with Primary Progressive Multiple Sclerosis (PPMS). Cellular therapies like the one are always being worked on, and stem cell treatments are...
